# Effects of Exenatide on Hypothalamic Obesity

> **NCT01061775** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospitals and Clinics of Minnesota** · enrollment: 19 (actual)

## Conditions studied

- Hypothalamic Obesity

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT01061775
- **Lead sponsor:** Children's Hospitals and Clinics of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-07
- **Final completion:** 2019-03-15
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061775, "Effects of Exenatide on Hypothalamic Obesity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01061775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*